1. 18F-fluorodeoxyglucose positron emission tomography in malignant pleural mesothelioma: diagnostic and prognostic performance and its correlation to pathological results
   Filippo Lococo et al, 2020, Interactive CardioVascular and Thoracic Surgery CrossRef
2. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Malignant Pleural Mesothelioma: What Is the Role in Mesothelioma Detection and Treatment Response Assessment?
   Kazuhiro Kitajima et al, 2021, Malignant Pleural Mesothelioma CrossRef
3. A PET-CT score for discriminating malignant from benign pleural effusions
   Marc Simó et al, 2023, Medicina Clínica (English Edition) CrossRef
4. Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma
   Egesta Lopci et al, 2015, European Journal of Nuclear Medicine and Molecular Imaging CrossRef
5. The Prognostic Value of 18F-FDG PET Imaging at Staging in Patients with Malignant Pleural Mesothelioma: A Literature Review
   Silvia Taralli et al, 2021, Journal of Clinical Medicine CrossRef
6. Pleural irregularities and mediastinal pleural involvement in early stages of malignant pleural mesothelioma and benign asbestos pleural effusion
   Katsuya Kato et al, 2016, European Journal of Radiology CrossRef
7. Diagnostic Accuracy of 18F-FDG-PET and PET/CT in the Differential Diagnosis between Malignant and Benign Pleural Lesions
   Giorgio Treglia et al, 2014, Academic Radiology CrossRef
8. Lungentumoren
   Wolfgang Mohnike et al, 2016, PET/CT-Atlas CrossRef
9. False-Negative 18F-Fluorodeoxyglucose PET/CT in Malignant Pleural Mesothelioma
   Haley Corbin et al, 2021, Cureus CrossRef
10. FDG PET/CT for Staging and Restaging Malignant Mesothelioma
    Egesta Lopci et al, 2022, Seminars in Nuclear Medicine CrossRef
11. Present and future roles of FDG-PET/CT imaging in the management of malignant pleural mesothelioma
    Kazuhiro Kitajima et al, 2016, Japanese Journal of Radiology CrossRef
12. 18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma
    David O. Hall et al, 2018, Nuclear Medicine Communications CrossRef
13. Phenotyping malignant pleural effusions
    Macy M.S. Lui et al, 2016, Current Opinion in Pulmonary Medicine CrossRef
14. “PET/CT Variants and Pitfalls in Lung Cancer and Mesothelioma”
    Egesta Lopci et al, 2021, Seminars in Nuclear Medicine CrossRef
15. Accuracy of Fluorodeoxyglucose-PET Imaging for Differentiating Benign From Malignant Pleural Effusions
    José M. Porcel et al, 2015, Chest CrossRef
16. A PET-CT score for discriminating malignant from benign pleural effusions
    Marc Simó et al, 2023, Medicina Clínica CrossRef
17. Prognostic value of pretreatment volume-based quantitative 18 F-FDG PET/CT parameters in patients with malignant pleural mesothelioma
    Kazuhiro Kitajima et al, 2017, European Journal of Radiology CrossRef
18. Positron emission tomography-computed tomography (PET-CT) in suspected malignant pleural effusion. An updated systematic review and meta-analysis
    Katrine Fjaellegaard et al, 2021, Lung Cancer CrossRef
19. Role of Metabolic Imaging in Mesothelioma
    Fabrizia Gelardi et al, 2019, Mesothelioma CrossRef
20. FDG PET versus CT radiomics to predict outcome in malignant pleural mesothelioma patients
    M. Pavic et al, 2020, EJNMMI Research CrossRef
21. Malignant pleural mesothelioma: an update on diagnosis and treatment options
    Sanjana Kondola et al, 2016, Therapeutic Advances in Respiratory Disease CrossRef
22. Lymphohistiocytoid mesothelioma of the pleura: A case report
    Hideyuki Nishi et al, 2016, The Journal of the Japanese Association for Chest Surgery CrossRef
23. Metabolic response assessment with 18F-FDG-PET/CT is superior to modified RECIST for the evaluation of response to platinum-based doublet chemotherapy in malignant pleural mesothelioma
    Shingo Kanemura et al, 2017, European Journal of Radiology CrossRef